Nippon India Pharma Fund

Nippon India Mutual Fund · Sectoral / Thematic · Regular Growth · AMFI 102431 · ISIN INF204K01968
NAV₹591.242920 Nov 2026
3Y return+16.91%a year
5Y return+14.37%a year
Expense ratio1.83%₹9,087 Cr
Growth Score78.1★★★★★

Returns

1M3M6MYTD1Y3Y5Y7Y10YSince launch
Fund+11.32%+3.52%+8.09%+16.05%+14.27%+16.91%+14.37%+21.46%+15.58%+17.64%
NIFTY Pharma TRI+10.85%+7.49%+14.67%+25.66%+25.86%+22.31%+16.87%———
Category middle+6.83%+0.56%+8.02%+3.99%+3.08%+13.34%+11.84%+16.65%+14.59%—

Risk (36 months)

Volatility14.10%
Sharpe0.74
Sortino1.15
Beta0.89
Alpha-2.75%
Deepest fall-47.36%
1-year periods with a loss23%
5Y SIP XIRR+17.18%

Top holdings (31 Oct 2026)

Sun Pharmaceutical Industries Limited11.55%
Divi's Laboratories Limited6.73%
Cipla Limited6.21%
Lupin Limited6.16%
Dr. Reddy's Laboratories Limited6.13%
Apollo Hospitals Enterprise Limited5.10%
Mankind Pharma Limited4.40%
Sai Life Sciences Limited4.04%
Ajanta Pharma Limited3.53%
Max Healthcare Institute Limited3.31%
IPCA Laboratories Limited2.90%
GlaxoSmithKline Pharmaceuticals Limited2.83%

Sectors

Pharmaceuticals & Biotechnology75.0%
Healthcare Services21.8%
Retailing2.3%
Healthcare Equipment & Supplies0.5%

Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.